2018
DOI: 10.1096/fj.201800858rr
|View full text |Cite
|
Sign up to set email alerts
|

BMP7 antagonizes proliferative vitreoretinopathy through retinal pigment epithelial fibrosis in vivo and in vitro

Abstract: The major pathogenesis of proliferative vitreoretinopathy (PVR) is that retinal pigment epithelial (RPE) cells undergo epithelial‐mesenchymal transition (EMT) because of disordered growth factors, such as TGF‐β, in the vitreous humor. Bone morphogenetic proteins (BMPs) are pluripotent growth factors. In this study, we identified the antifibrotic activity of BMP7 in a PVR model both in vivo and in vitro. BMP7 expression was confirmed on the PVR proliferative membranes. BMP7 was down‐regulated in the PVR vitreou… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
25
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 37 publications
(27 citation statements)
references
References 38 publications
2
25
0
Order By: Relevance
“…Previous studies indicated that TGF-b1 and TGF-b2 are capable of modulating the PVR environment in vitro (including initiating EMT and migration in RPE) and have both been widely used in related studies. 5,14,16,[22][23][24][25] Our previous study 16 confirmed that TGF-b1 and TGF-b2 elicited similar EMT-initiating effects, including the downregulation of the expression of E-cadherin and ZO-1. Considering the similar effects of TGF-b1 and TGF-b2 in RPE cells and the predominant use of TGF-b1 in our laboratory, only TGF-b1 was used in this study.…”
Section: Discussionsupporting
confidence: 61%
“…Previous studies indicated that TGF-b1 and TGF-b2 are capable of modulating the PVR environment in vitro (including initiating EMT and migration in RPE) and have both been widely used in related studies. 5,14,16,[22][23][24][25] Our previous study 16 confirmed that TGF-b1 and TGF-b2 elicited similar EMT-initiating effects, including the downregulation of the expression of E-cadherin and ZO-1. Considering the similar effects of TGF-b1 and TGF-b2 in RPE cells and the predominant use of TGF-b1 in our laboratory, only TGF-b1 was used in this study.…”
Section: Discussionsupporting
confidence: 61%
“…TGF-β induces EMT of RPE cells via two pathways: the classical SMAD-dependent pathway and the SMAD-independent pathway ( Fig. 2 ) ( Cai et al, 2018 ; He et al, 2017 ; Heffer et al, 2019 ; Ishikawa et al, 2015 ; Takahashi, Haga & Tanihara, 2015 ; Yao et al, 2019 ; Zhang et al, 2017 ; Zhang et al, 2018b ; Zhou et al, 2017 ). In the SMAD dependent pathway, TGF-β binds to cell surface receptor complexes, and activates type I TGF-β receptors, which phosphorylate SMAD2 and SMAD3.…”
Section: Survey Methodologymentioning
confidence: 99%
“…A prior study showed that an RAR-γ agonist inhibits the development of subretinal fibrosis in mice by inhibiting the TGF-β pathway (Kimura et al, 2015). Bone morphogenetic proteins (BMPs) are pluripotent growth factors which have anti-fibrotic activity (Yao et al, 2019). Injections of BMP7 in a rabbit PVR model maintained RPE cell phenotypes and prevented TGF-β2-induced EMT, migration and gel contraction (Yao et al, 2019).…”
Section: Therapeutic Implicationsmentioning
confidence: 99%
“…Bone morphogenetic proteins (BMPs) are pluripotent growth factors which have anti-fibrotic activity (Yao et al, 2019). Injections of BMP7 in a rabbit PVR model maintained RPE cell phenotypes and prevented TGF-β2-induced EMT, migration and gel contraction (Yao et al, 2019). Anti-inflammatory agents, including Bortezomib, a proteasome inhibitor that regulates the NF-κB pathway, and resveratrol, a polyphenol phytoalexin and heavy chain-hyaluronan/pentraxin3, inhibit EMT in RPE cells and prevent PVR development by downregulating the TGF-β pathway (Ishikawa et al, 2015;He et al, 2017;Moon et al, 2017).…”
Section: Therapeutic Implicationsmentioning
confidence: 99%